4.6 Letter

Non-office-hours admission affects intravenous thrombolysis treatment times and clinical outcome

Journal

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2017-316791

Keywords

-

Funding

  1. Boehringer-Ingelheim
  2. Medtronic
  3. Swiss National Science Foundation
  4. Swiss Heart Foundation
  5. Cardiomet-CHUV
  6. Bayer
  7. Covidien
  8. St. Jude Medical
  9. Pierre-Fabre
  10. Sanofi Aventis
  11. BMS
  12. AstraZeneca
  13. Servier
  14. Ebewe
  15. CoLucid Pharm
  16. Brainsgate
  17. Photothera
  18. Lundbeck
  19. GSK
  20. Pfizer
  21. Allergan
  22. German Ministry of research and education
  23. BMS/Pfizer
  24. Sanofi
  25. Science Funds [Wissenschaftsfonds] of the University Hospital Basel
  26. Boehringer Ingelheim

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available